Onko-Gene

Critical literature watch in the molecular oncology of solid tumors

FREN

Clinical

Exploring spatial heterogeneity of PD-L1 and c-MET expression in oral squamous cell carcinoma

Summary

This retrospective study investigated the spatial heterogeneity of PD-L1 and c-MET expression in oral squamous cell carcinoma (OSCC) by comparing primary tumors and matched lymph node metastases. Findings revealed that both PD-L1 and c-MET were frequently expressed in primary tumors but at significantly lower levels in corresponding lymph node metastases. A substantial discordance in PD-L1 CPS status was observed between the two tumor compartments, potentially impacting biomarker classification. While higher PD-L1 expression in primary tumors was associated with nodal metastasis, no significant correlation was found between PD-L1 and c-MET. These results highlight the critical role of spatial heterogeneity in biomarker assessment for OSCC.

Critical appraisal

This retrospective cohort study highlights a pronounced spatial heterogeneity of PD-L1 and c-MET expression between primary tumors and lymph node metastases in OSCC. This discordance, particularly for PD-L1, is clinically relevant as PD-L1 is an established predictive biomarker for immune checkpoint inhibitor therapy. Assessing PD-L1 status solely from the primary tumor might not accurately reflect the status of metastatic lesions, potentially leading to suboptimal treatment decisions. These findings suggest that biomarker assessment should ideally encompass both tumor compartments, or at least consider the implications of this heterogeneity. Larger prospective studies are warranted to confirm these observations and determine their definitive impact on clinical practice and future trials, potentially within 3 to 5 years.

The summary and the appraisal were written by a language model from the title and abstract of the original article. A curator decided to publish it. Methodology